Penile Cancer in the Region of Thies: Epidemiological, Diagnostic and Therapeutic Aspects

Crossmark: check for updates

Authors

  • Saint C. N. Kouka Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Tonleu L. Bentefouet Department of Anatomy Pathology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Ngor M. Thiam Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Modou Faye Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Mbayang Diop Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Mouhamed Cisse Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Mohamed Jalloh Department of Urology, University Cheikh Anta Diop De Dakar, Dakar, Senegal
  • Aissatou A. Diame Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Yoro Diallo Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal
  • Sylla Cheikhna Department of Urology, University Iba Der Thiam of Thies,Thiès, Senegal

DOI:

https://doi.org/10.17140/UAOJ-7-145

Keywords:

Penile cancer, Histopathology, Thies, Therapeutic management, Urogenital cancer, Squamous cell carcinoma

Abstract

Aim
This study aimed to determine the epidemiological, clinical, histopathological, and therapeutic characteristics of patients with penile cancer in hospitals in the Thiès region.
Patients and Methods
We conducted a retrospective descriptive study collecting all cases of penile cancer in the different urology departments in the Thies region from January 1st, 2015, to December 31st, 2020.
Results
We recorded 14 cases of penile cancer during the study period. The average age of the patients was 42.93-years (range: 26 to 82-years). The average consultation time was 18-months. All patients were circumcised during childhood. The circumstances of discovery were penile pain (64.3%), ulceration of the penis (26.6%), and hematuria (14.3%). Squamous cell carcinoma was found in 100% of patients. The cancer was locally advanced or metastatic in 64.3% of cases. Partial amputation of the penis was carried out in 50% of patients, and total amputation of the penis was carried out in 42.85% of patients. One patient refused a total penile amputation. After a 6-month follow-up, 35.7% of patients had died.
Conclusion
The presentation of penile cancers is often late in the Thiès region. Improving the technical platform will make it possible to better manage these cancers.

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 392-424. doi: 10.3322/caac.21492

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: Cancer J Clin. 2022; 72: 7-33. doi: 10.3322/caac.21708

Hakenberg O, Compérat E, Minhas S, Necchi A, Protzel C, Watkin N. EAU Guidelines on Penile Cancer. 2022. Website. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Penile-Cancer-2022.pdf. Accessed November 10, 2023.

Gueye SG, Diagne BA, Ba M, Sylla C, Mensah A. Le cancer de la verge: Aspects épidémiologiques et problèmes thérapeutiques au Sénégal. [In: French]. Med Afr Noire. 1992; 39: 8-9. http://www. santetropicale.com/Resume/93907.pdf. Accessed November 10, 2023.

Sow Y, Thiam A, Fall B, et al. Cancer du pénis au Sénégal: Aspects cliniques et thérapeutiques. [In: French]. Andrologie. 2012; 22: 102-107. doi: 10.1007/s12610-012-0176-1

Kouka SCN, Diallo Y, Seck F, et al. Penile cancer: Report of 3 cases and review of the literature. Med Sur Urol. 2017; 6: 1. doi: 10.4172/2168-9857.1000182

Cassell A, Yunusa B, Manobah B, Wambo D. Management guidelines of penile cancer- a contemporary review of sub-Saharan Africa. Infect Agent Cancer. 2020; 15: 26. doi: 10.1186/s13027-020- 00293-9

Magoha GA, Ngumi ZW. Cancer of the penis at Kenyatta National Hospital. East Afr Med J. 2000; 77(10): 526-530. doi: 10.4314/eamj.v77i10.46706

Luciano AF, Aguinaldo CN, Mario R, Zequi SC, Sampaio FJB, Glina S. Epidemiologic study on penile cancer in Brazil. Int Braz J Urol. 2008; 34: 587-591. doi: 10.1590/s1677-55382008000500007

Chalya PL, Rambau PF, Masalu N, Simbila S. Ten-year surgical experiences with penile cancer at a tertiary care hospital Original Research | Volume 7 | Number 1| Kouka SCN, et al in northwestern Tanzania: A retrospective study of 236 patients. World J Surg Oncol. 2015; 13: 71. doi: 10.1186/s12957-015-0482-0

Mottet N. Épidémiologie du cancer du pénis. [In: French]. Prog Urol. 2003; 13(5 Suppl 2): 1237.

Pascual A, Pariente M, Godinez JM, et al. High prevalence of human papillomavirus 16 in penile carcinoma. Histol Histopathol. 2007; 22(2): 177-183. doi: 10.14670/HH-22.177

Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007; 25: 361-367. doi: 10.1016/j.urolonc.2006.08.029

Savoie P-H, Morel-Journel N, Murez T, et al. [French ccAFU guidelines - update 2020-2022: Penile cancer]. Prog Urol. 2020; 30(12S): S252-S279. doi: 10.1016/S1166-7087(20)30753-3

Renaud-Vilmer C, Cavelier-Balloy B, Verola O, et al. Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma. J Am Acad Dermatol. 2010; 62: 284-290. doi: 10.1016/j.jaad.2009.06.087

Rigaud J, Avancès C, Camparo P, et al. [Recommandations en Onco-Urologie 2010: Tumeurs malignes du pénis]. [In: French]. Prog Urol. 2010; 20 Suppl 4: S279-S289. doi: 10.1016/S1166- 7087(10)70044-0

Stankiewicz E, Kudahetti SC, Prowse DM, et al. HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod Pathol. 2009; 22: 1160-1168. doi: 10.1038/modpathol.2009.77

Kayes O, Ahmed HU, Arya M, Minhas S. Molecular and genetic pathways in penile cancer. Lancet Oncol. 2007; 8(5): 420-429. doi: 10.1016/S1470-2045(07)70137-7

Bentefouet TL, Wardi AE, Diop Y, Sarr EHS, Diousse P, Kouka SC, Diallo Y. Carcinome à cellules fusiformes (sarcomatoide) du pénis. A propos d’un cas. [In: French]. Mali Médical. 2020; 35(35): 56-59.

Bozzini G, Provenzano M, Otero JR, et al. Role of penile doppler US in the preoperative assessment of penile squamous cell carcinoma patients: Results from a large prospective multicenter European study. Urology. 2016; 90: 131-135. doi: 10.1016/j. urology.2016.01.003

Krishna S, Schieda N, Kulkarni GS, Shanbhogue K, Baroni RH, Woo S. Diagnostic accuracy of MRI in local staging (T Category) of penile cancer and the value of artificial erection: A systematic review and meta-analysis. AJR Am J Roentgenol. 2022; 219(1): 28- 36. doi: 10.2214/AJR.21.27063

Lesourd A. Anatomo-pathologie des tumeurs malignes du pénis. [In: French]. Progrès en Urologie. 2005; 15: 801-804.

Lont AP, Galle MP, Snijders P, Horenblas S. Sarcomatoïd squamous cell carcinoma of the penis: A clinical pathological study of 5 cases. J Urol. 2004; 172: 932-935. doi: 10.1097/01. ju.0000136363.90911.e5

Avancès C, Bastide C, Mottet N. Prise en charge actuelle des tumeurs du pénis. [In: French]. Urologie. 2007; 18-375-A-10. doi : 10.1016/S0000-0000(07)30008-9

Guimaraes GC, Lopes A, Campos RS, et al. Front pattern of Submit your article to this journal | https://openventio.org/online-manuscript-submission-system/ invasion in squamous cell carcinoma of the penis: New prognostic factor for predicting risk of lymph node metastases. Urology. 2006; 68: 148-153. doi: 10.1016/j.urology.2006.01.050

Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol. 2009; 27: 169- 177. doi: 10.1007/s00345-008-0315-7

Downloads

Published

2024-02-08

How to Cite

Saint C. N. Kouka, Tonleu L. Bentefouet, Ngor M. Thiam, Modou Faye, Mbayang Diop, Mouhamed Cisse, … Sylla Cheikhna. (2024). Penile Cancer in the Region of Thies: Epidemiological, Diagnostic and Therapeutic Aspects. Urology and Andrology , 7(1), 12–17. https://doi.org/10.17140/UAOJ-7-145

Issue

Vol. 7 No. 1 (2023): Volume 7 Issue 1 2023

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Urology and Andrology (UA) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.

Most read articles by the same author(s)